Chiriboga C A
Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Ann N Y Acad Sci. 1998 Jun 21;846:109-25.
Cocaine is a highly psychoactive substance with numerous effects that readily crosses the placenta, achieving variables levels in the fetus. Determining whether prenatal exposure to cocaine and its metabolites damages the developing human nervous system is hindered by the multiple intervening factors (confounders) that plague clinical settings, which warrant consideration in controlled studies. Prenatal cocaine exposure has been linked to numerous adverse neonatal outcomes, affecting fetal growth (i.e., low birth weight, intrauterine growth retardation, and small head size) and neurobehavior. These neurobehavior effects span the gamut from no abnormalities to impairments in arousal, neurological function, neurophysiological function, and state regulation. Strokes and possibly seizures are also noted. Dose-response effects of fetal cocaine exposure on fetal growth and neonatal neurobehavior are reported using quantitative methods of ascertainment. In early infancy, irritability and hypertonia are also described. Most cocaine associations are transient and resolve in infancy and early childhood. Whether such transient abnormalities place infants at increased risk for later neurodevelopmental impairments is not known. Controlled studies have found no cognitive differences related to prenatal cocaine exposure among toddlers or school age children, except as mediated through effects on head growth. Anecdotally, cocaine-exposed children seem to suffer from neurobehavioral abnormalities, but to date controlled studies have not established an association between cocaine and behavioral disorders, except for inattentiveness. Despite encouraging reports, the question of whether cocaine exerts long-term adverse effects on the developing human nervous system has not yet been resolved, largely because of the limitations of existing studies that rely on inadequate, mostly qualitative ascertainment of cocaine exposure as well as the dearth of studies in older children. Such methodological limitations may have compromised our ability to identify cocaine-exposed children at most risk.
可卡因是一种具有多种效应的高度精神活性物质,它很容易穿过胎盘,在胎儿体内达到不同水平。由于困扰临床环境的多种干预因素(混杂因素),确定产前接触可卡因及其代谢产物是否会损害发育中的人类神经系统受到阻碍,而这些因素在对照研究中值得考虑。产前接触可卡因与许多不良新生儿结局有关,影响胎儿生长(即低出生体重、宫内生长迟缓、小头围)和神经行为。这些神经行为效应范围广泛,从无异常到觉醒、神经功能、神经生理功能和状态调节受损。还发现有中风以及可能的癫痫发作。使用定量确定方法报告了胎儿接触可卡因对胎儿生长和新生儿神经行为的剂量反应效应。在婴儿早期,还描述了易怒和张力亢进。大多数与可卡因相关的情况是短暂的,在婴儿期和幼儿期会消失。尚不清楚这种短暂异常是否会使婴儿日后出现神经发育障碍的风险增加。对照研究发现,除了通过对头部生长的影响介导外,学步儿童或学龄儿童中与产前接触可卡因无关的认知差异。据传闻,接触可卡因的儿童似乎患有神经行为异常,但迄今为止,对照研究尚未证实可卡因与行为障碍之间存在关联,除了注意力不集中。尽管有令人鼓舞的报告,但可卡因是否会对发育中的人类神经系统产生长期不良影响的问题尚未得到解决,这主要是因为现有研究存在局限性,这些研究依赖于对可卡因接触情况的不充分、大多是定性的确定,以及大龄儿童研究的匮乏。这种方法上的局限性可能损害了我们识别最易接触可卡因儿童的能力。